| Literature DB >> 17907862 |
Maxine L Stitzer1, Nancy Petry, Jessica Peirce, Kimberly Kirby, Therese Killeen, John Roll, John Hamilton, Patricia Q Stabile, Robert Sterling, Chanda Brown, Ken Kolodner, Rui Li.
Abstract
Intake urinalysis test result (drug positive vs. negative) has been previously identified as a strong predictor of drug abuse treatment outcome, but there is little information about how this prognostic factor may interact with the type of treatment delivered. The authors used data from a multisite study of abstinence incentives for stimulant abusers enrolled in outpatient counseling treatment (N. M. Petry, J. M. Peirce, et al., 2005) to examine this question. The first study urine was used to stratify participants into stimulant negative (n = 306) versus positive (n = 108) subgroups. Abstinence incentives significantly improved retention in those testing negative but not in those testing positive. Findings suggest that stimulant abusers presenting to treatment with a stimulant-negative urine benefit from abstinence incentives, but alternative treatment approaches are needed for those who test stimulant positive at intake. (PsycINFO Database Record (c) 2007 APA, all rights reserved).Entities:
Mesh:
Substances:
Year: 2007 PMID: 17907862 DOI: 10.1037/0022-006X.75.5.805
Source DB: PubMed Journal: J Consult Clin Psychol ISSN: 0022-006X